NEW
YORK, June 25, 2024 /PRNewswire/ -- The
global cell culture consumables market size is estimated
to grow by USD 48.26 billion
from 2024-2028, according to Technavio. The market is estimated to
grow at a CAGR of almost 31.31% during the forecast
period.
The cell culture consumables market is thriving, fueled by the
rise of biopharmaceutical production and the growing adoption of
single-use technologies. These disposable tools are revolutionizing
cell culture by streamlining production and reducing costs.
However, the market faces a significant challenge:
contamination.
Research report provides comprehensive data on impact of trend.
For more details- Download a Sample Report
Here's a breakdown of the key trends:
Growth Drivers:
- Biopharma Boom: The increasing demand for vaccines and
protein therapeutics is driving the need for cell culture
consumables, especially media, sera, and reagents.
- Single-Use Advantage: Single-use technologies offer a
cost-effective and efficient way to manufacture biopharmaceuticals.
They eliminate the need for cleaning and sterilization, saving time
and money.
- Research Advancements: Growing research in areas
like stem cell therapy and gene editing is creating a demand for
specialized cell culture consumables.
Challenges to Address:
- Contamination Risk: Impurities in media, water, and
equipment can contaminate cell cultures, leading to financial
losses and hampering productivity.
Market Segments:
- Biopharma Production: This dominates the market due to
the high demand for consumables in vaccine and protein
manufacturing.
- Cancer Research: A substantial segment due to the use of
cell culture in developing cancer treatments.
- Other Applications: This includes drug discovery,
toxicology testing, and cell-based therapies.
Geographic Landscape:
- North America:
Currently leads the market, but Asia is expected to see significant growth due
to rising investment in biotechnology.
Future Outlook:
The cell culture consumables market is projected for continued
growth due to advancements in biopharmaceuticals and research.
Innovation in areas like contamination control and cost-effective
solutions will be crucial for sustained market expansion.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Application
-
- Biopharmaceutical Production
- Cancer Research
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cell-culture-consumables-market-size-is-set-to-grow-by-usd-48-26-billion-from-2024-2028--rise-in-production-of-cell-culture-based-viral-vaccines-to-boost-the-market-growth-technavio-302181398.html
SOURCE Technavio